# DEtection of Cellular Inflammation With FERumoxytol in the HEART

> **NCT02319278** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 58 (actual)

## Conditions studied

- Cardiac Transplant
- Cardiac Sarcoid
- Myocarditis
- Healthy Volunteers

## Interventions

- **DRUG:** Ferumoxytol

## Key facts

- **NCT ID:** NCT02319278
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319278, "DEtection of Cellular Inflammation With FERumoxytol in the HEART". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02319278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*